Rho Celebrates 25th Anniversary
Chapel Hill, NC
October 24, 2009 marked the 25th Anniversary for Rho, a Chapel Hill based contract research organization. Established in 1984, Rho began as a small, family run business in the basement of the home of Ron and Mary Helms. Since then, it has rapidly developed into a large family owned company that conducts business with some of the most dynamic pharmaceutical, biotech, and medical device companies in the U.S.
During the past 25 years, Rho has acquired a strong commercial and federal customer base because of its customer service and scientific expertise. Consulting to the FDA, rescuing poorly executed pivotal trials, authoring and coauthoring 252 articles, 89 presentations, and 82 abstracts are
among of Rho’s accomplishments.
Rho contributes to the success of pharmaceutical, medical device, and biotechnology studies in a range of therapeutic areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
